Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Caracciolo

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Experimental Hematology|February 1, 1994
Selection and characterization of early hematopoietic progenitors using an anti-CD71/S06 immunotoxinG Benedetti, P Bondesan, D Caracciolo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
High-dose sequential chemoradiotherapy, a widely applicable regimen, confers survival benefit to patients with high-risk multiple myelomaA M Gianni, C Tarella, M Bregni, et al.
Bone Marrow Transplantation|April 1, 1993
Role of chemotherapy and GM-CSF on hemopoietic progenitor cell mobilization in multiple myelomaC Tarella, M Boccadoro, P Omedé, et al.
Bone Marrow Transplantation|August 1, 1995
Circulating progenitors following high-dose sequential (HDS) chemotherapy with G-CSF: short intervals between drug courses severely impair progenitor mobilizationC Tarella, D Caracciolo, P Gavarotti, et al.
British Journal of Haematology|November 1, 1995
Both early and committed haemopoietic progenitors are more frequent in peripheral blood than in bone marrow during mobilization induced by high-dose chemotherapy + G-CSFC Tarella, G Benedetti, D Caracciolo, et al.
Annals of Hematology|September 12, 2002
Feasibility of peripheral blood progenitor cell mobilization and harvest to support chemotherapy intensification in elderly patients with poor prognosis: non-Hodgkin's lymphomaF Zallio, A Cuttica, D Caracciolo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1987
Establishment and characterization of an undifferentiated human T leukemia cell line which requires granulocyte-macrophage colony stimulatory factor for growthM Valtieri, D Santoli, D Caracciolo, et al.
Leukemia|September 14, 1999
Negative immunomagnetic ex vivo purging combined with high-dose chemotherapy with peripheral blood progenitor cell autograft in follicular lymphoma patients: evidence for long-term clinical and molecular remissionsC Tarella, P Corradini, M Astolfi, et al.
Bone Marrow Transplantation|October 20, 2009
Comparative assessment of telomere length before and after hematopoietic SCT: role of grafted cells in determining post-transplant telomere statusM Ruella, A Rocci, I Ricca, et al.
Bone Marrow Transplantation|September 11, 1998
Allogeneic transplantation of unmanipulated peripheral blood stem cells in patients with multiple myelomaI Majolino, P Corradini, R Scimè, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Experimental Hematology|February 1, 1994
Selection and characterization of early hematopoietic progenitors using an anti-CD71/S06 immunotoxinG Benedetti, P Bondesan, D Caracciolo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
High-dose sequential chemoradiotherapy, a widely applicable regimen, confers survival benefit to patients with high-risk multiple myelomaA M Gianni, C Tarella, M Bregni, et al.
Bone Marrow Transplantation|April 1, 1993
Role of chemotherapy and GM-CSF on hemopoietic progenitor cell mobilization in multiple myelomaC Tarella, M Boccadoro, P Omedé, et al.
Bone Marrow Transplantation|August 1, 1995
Circulating progenitors following high-dose sequential (HDS) chemotherapy with G-CSF: short intervals between drug courses severely impair progenitor mobilizationC Tarella, D Caracciolo, P Gavarotti, et al.
British Journal of Haematology|November 1, 1995
Both early and committed haemopoietic progenitors are more frequent in peripheral blood than in bone marrow during mobilization induced by high-dose chemotherapy + G-CSFC Tarella, G Benedetti, D Caracciolo, et al.
Annals of Hematology|September 12, 2002
Feasibility of peripheral blood progenitor cell mobilization and harvest to support chemotherapy intensification in elderly patients with poor prognosis: non-Hodgkin's lymphomaF Zallio, A Cuttica, D Caracciolo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1987
Establishment and characterization of an undifferentiated human T leukemia cell line which requires granulocyte-macrophage colony stimulatory factor for growthM Valtieri, D Santoli, D Caracciolo, et al.
Leukemia|September 14, 1999
Negative immunomagnetic ex vivo purging combined with high-dose chemotherapy with peripheral blood progenitor cell autograft in follicular lymphoma patients: evidence for long-term clinical and molecular remissionsC Tarella, P Corradini, M Astolfi, et al.
Bone Marrow Transplantation|October 20, 2009
Comparative assessment of telomere length before and after hematopoietic SCT: role of grafted cells in determining post-transplant telomere statusM Ruella, A Rocci, I Ricca, et al.
Bone Marrow Transplantation|September 11, 1998
Allogeneic transplantation of unmanipulated peripheral blood stem cells in patients with multiple myelomaI Majolino, P Corradini, R Scimè, et al.
Pageof 5